Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma
Open Access
- 1 July 1989
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 60 (1) , 104-106
- https://doi.org/10.1038/bjc.1989.230
Abstract
Flavone acetic acid (FAA), 8.6 gm-2 has been administered by 6h intravenous infusion to 19 patients with advanced colorectal carcinoma and 15 patients with advanced malignant melanoma. The drug associated toxicity was generally mild and as predicted from the phase I study. No responses were seen in either disease.Keywords
This publication has 10 references indexed in Scilit:
- Immunomodulation of Natural Killer Cell Activity by Flavone Acetic Acid: Occurrence Via Induction of Interferon /betaJNCI Journal of the National Cancer Institute, 1988
- FLAVONE ACETIC-ACID (NSC 347512)-INDUCED MODULATION OF MURINE TUMOR PHYSIOLOGY MONITORED BY INVIVO NUCLEAR MAGNETIC-RESONANCE SPECTROSCOPY1988
- FLAVONE ACETIC-ACID (NSC 347512)-INDUCED DNA DAMAGE IN GLASGOW OSTEOGENIC-SARCOMA INVIVO1988
- IMMUNE THROMBOCYTOPENIA CAUSED BY FLAVONE-8-ACETIC ACIDThe Lancet, 1988
- PHASE-I AND PHARMACOKINETIC STUDY OF FLAVONE ACETIC-ACID1987
- Flavone acetic acid (NSC 347512) induces haemorrhagic necrosis of mouse colon 26 and 38 tumoursEuropean Journal of Cancer and Clinical Oncology, 1987
- THERAPEUTIC AND PHARMACOKINETIC RELATIONSHIPS OF FLAVONE ACETIC-ACID - AN AGENT WITH ACTIVITY AGAINST SOLID TUMORS1986
- PHASE-I AND PHARMACOKINETIC STUDY OF LM985 (FLAVONE ACETIC-ACID ESTER)1986